TORONTO, June 04, 2024 (GLOBE NEWSWIRE) -- Sulliden Mining Capital Inc. (TSX: SMC) (“Sulliden” or the “Company”) announces today that Grant Sboros has resigned as a director of the Company. The board and management of Sulliden express their gratitude to Mr. Sboros for his efforts and contributions and wish him well in his future endeavours. About Sulliden Sulliden is a mining company focused on acquiring and advancing brownfield, development-stage, and early production-stage mining projects. Sulliden Mining Capital Inc.On behalf of the Board“Scott Moore”, Chief Executive Officerinfo@sulliden.com(416) 861-2267 THE TSX HAS NOT REVIEWED AND ...

LONDON, ON and BOSTON, June 6, 2024 /CNW/ - Sernova Corp. ("Sernova" or the "Company") (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH) is pleased to announce that it has filed a preliminary short form prospectus in connection with a best efforts marketed public offering (the "Offering") of units of the Company (the "Units"). The Offering is being led by Stifel Nicolaus Canada Inc., as lead agent (the "Lead Agent") and joint bookrunner with Leede Jones Gable Inc., on behalf of a syndicate of agents that includes Ventum Financial Corp., Raymond James, Research Capital Corporation and Roth Canada, Inc. (together with the Lead Agent, the "Agents") and is for minimum ...

– Acquisition Would Enable VersaBank to Broadly Launch its Unique and Highly Successful Receivable Purchase Program Financing Solution in the United States – LONDON, ON, June 7, 2024 /CNW/ - VersaBank (TSX: VBNK) (NASDAQ: VBNK), a North American leader in business-to-business digital banking, as well as technology solutions for cybersecurity, today announced it has received formal approval of its proposed acquisition of Minnesota-based Stearns Bank Holdingford (the "Stearns Holdingford Acquisition"), a national OCC-licensed bank, from the U.S. Federal Reserve. The Federal Reserve is one of two U.S. regulatory approvals required for VersaBank to proceed with the Stearns Holdingford Acquisition. VersaBank expects a decision ...

VANCOUVER, BC, June 7, 2024 /CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a leader in mental health care specializing in innovative and evidence-based treatments, comments on the results of June 4, 2024 meeting of the U.S. Food and Drug Administration's ("FDA") Psychopharmacologic Drugs Advisory Committee ("PDAC"). The independent committee reviewed Lykos Therapeutics' new drug application for MDMA (midomafetamine capsules) used in combination with psychological intervention for individuals with post-traumatic stress disorder ("PTSD"). The PDAC voted against recommending approval of MDMA for PTSD in a majority decision where 2 of 11 found that the available data demonstrates ...